Extended-Release Tacrolimus Plus Everolimus or Micophenolate Mofetil in Deceased Donor Kidney Transplant Recipients: 6-Month Results of a Prospective Randomized Clinical Trial

被引：0
|
作者：
Favi, E. [1 ]
Silvestrini, N. [1 ]
Salerno, M. P. [1 ]
Romagnoli, J. [1 ]
Citterio, F. [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Renal Transplant Unit, Dept Surg Sci, Rome, Italy
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
55
引用
收藏
页码：42 / 43
页数：2
相关论文
共 50 条
  • [1] Extended-Release Tacrolimus Plus Everolimus vs Extended-Release Tacrolimus Plus Micophenolate Mofetil in Primary Deceased Donor Kidney Transplant Recipients: 1-Year Results of an Open Label, Randomized Phase 2 Clinical Trial.
    Favi, E.
    Silvestrini, N.
    Pedroso, J.
    Salerno, M.
    Spagnoletti, G.
    Bianchi, V.
    Romagnoli, J.
    Citterio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 316 - 316
  • [2] Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial
    Favi, Evaldo
    Spagnoletti, Gionata
    Salerno, Maria P.
    Pedroso, Jose A.
    Romagnoli, Jacopo
    Citterio, Franco
    CLINICAL TRANSPLANTATION, 2013, 27 (04) : E359 - E367
  • [3] Thymoglobulin Plus Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplant Recipients Treated with Tacrolimus and Mycophenolate Mofetil: 1-Year Results of a Prospective Clinical Trial.
    Favi, E.
    Spagnoletti, G.
    Silvestrini, N.
    Salerno, M.
    Pedroso, J.
    Romagnoli, J.
    Citterio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 426 - 426
  • [4] A RANDOMIZED CLINICAL TRIAL OF EARLY CONVERSION FROM TACROLIMUS TO EVEROLIMUS IN DECEASED DONOR KIDNEY TRANSPLANTATION
    Pacheco e Silva, Alvaro
    Tonato, Eduardo
    Durao, Marcelino, Jr.
    Requiao-Moura, Lucio
    Arruda, Erika
    Chinen, Rogerio
    Filliponi, Thiago
    Melo, Luciana
    Matos, Ana
    TRANSPLANT INTERNATIONAL, 2013, 26 : 277 - 278
  • [5] Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients
    Trofe-Clark, Jennifer
    Brennan, Daniel C.
    West-Thielke, Patricia
    Milone, Michael C.
    Lim, Mary Ann
    Neubauer, Robin
    Nigro, Vincenza
    Bloom, Roy D.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (03) : 315 - 326
  • [6] THYMOGLOBULIN PLUS BASILIXIMAB VERSUS BASILIXIMAB INDUCTION IN DECEASED DONOR KIDNEY TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS AND MMF: 1-YEAR RESULTS OF A PROSPECTIVE CLINICAL TRIAL
    Favi, Evaldo
    Spagnoletti, Gionata
    Silvestrini, Nicola
    Salerno, Maria P.
    Pedroso, Jose A.
    Romagnoli, Jacopo
    Citterio, Franco
    TRANSPLANT INTERNATIONAL, 2013, 26 : 83 - 83
  • [7] A Noninferiority, Randomized Controlled Trial of Late Conversion to Once-Daily Regimen of Sirolimus and Extended-Release Tacrolimus Versus Mycophenolic Acid and Extended-Release Tacrolimus for Kidney Transplant Recipients (ODKT Trial)
    Kitrungphaiboon, Thidarat
    Udomkanjananan, Suwasin
    Thammathiwat, Theerachai
    Tiankanon, Kanitha
    Kupatawintu, Pawinee
    Iampenkhae, Kroonpong
    Limbutara, Kavee
    Pongpirul, Krit
    Avihingsanon, Yingyos
    Townamchai, Natavudh
    TRANSPLANTATION, 2022, 106 (09) : S138 - S138
  • [8] Five Years Results of De Novo Kidney Transplant Recipients Treated with the Combination of Low Dose Tacrolimus and Everolimus: A Prospective Randomized Clinical Trial
    Silvestri, P.
    Spagnoletti, G.
    Salerno, M.
    Favi, E.
    Zanoni, N.
    Citterio, F.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S449 - S449
  • [9] A randomized, open-label pharmacokinetic trial of tacrolimus extended-release dosing in obese de novo kidney transplant recipients
    Jasiak-Panek, Natalia M.
    Wenzler, Eric
    Patel, Shree
    Thielke, James J.
    Progar, Kristin
    Patel, Shitalben
    Brandt, Shane
    Huang, Yi-jen
    Benedetti, Enrico
    West-Thielke, Patricia M.
    CLINICAL TRANSPLANTATION, 2019, 33 (08)
  • [10] ER-TACROLIMUS PLUS EVEROLIMUS VS ER-TACROLIMUS PLUS MMF IN PRIMARY DECEASED DONOR KIDNEY TRANSPLANTATION: 1-YEAR RESULTS OF SINGLE CENTER, OPEN LABEL, PROSPECTIVE, RANDOMIZED CLINICAL TRIAL
    Favi, Evaldo
    Silvestrini, Nicola
    Pedroso, Jose Alberto
    Salerno, Maria Paola
    Spagnoletti, Gionata
    Romagnoli, Jacopo
    Citterio, Franco
    TRANSPLANT INTERNATIONAL, 2013, 26 : 241 - 241
12345